These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
153 related articles for article (PubMed ID: 22554361)
1. A cross sectional observational study on the influence of chronic obstructive pulmonary disease on activities of daily living: the COPD-Life study. Polatlı M; Bilgin C; Şaylan B; Başlılar Ş; Toprak E; Ergen H; Bakan ND; Kart L; Kılıç Z; Üstünel A; Şengün A; Varol Y; Yılmaz A; Ataol Ç; Bulgur D; Bozdoğan S; Tunaboyu İ; Özkan ZG; Uysal E; Gülgösteren S; Akın N; Selim Y; Irmak M; Turgut E; Keskin O; Bektaş Uysal H; Sofuoğlu N; Yılmaz M; Tuberk Toraks; 2012; 60(1):1-12. PubMed ID: 22554361 [TBL] [Abstract][Full Text] [Related]
2. A cross-sectional observational study to investigate daily symptom variability, effects of symptom on morning activities and therapeutic expectations of patients and physicians in COPD-SUNRISE study. Kuyucu T; Güçlü SZ; Saylan B; Demir C; Senol T; Güner S; Koyuncu E; Ozen F; Oztürk S; Cangül Z; Ağanoğlu S; Ozkaya S; Ocak SC; Akkurt H; Intepe YS; Bayrak MG; Güler T; Bekçi TT; Soyyiğit S; Seyfettin S; Kula O; Akbay MO; Büyükgöze B; Asal G; Başlilar S; Oztürk O; Tuberk Toraks; 2011; 59(4):328-39. PubMed ID: 22233302 [TBL] [Abstract][Full Text] [Related]
3. Factors associated with medication adherence in patients with chronic obstructive pulmonary disease. Ágh T; Inotai A; Mészáros Á Respiration; 2011; 82(4):328-34. PubMed ID: 21454953 [TBL] [Abstract][Full Text] [Related]
4. Tiotropium bromide. A review of its use as maintenance therapy in patients with COPD. Keam SJ; Keating GM Treat Respir Med; 2004; 3(4):247-68. PubMed ID: 15350163 [TBL] [Abstract][Full Text] [Related]
5. Symptoms and impact of COPD assessed by an electronic diary in patients with moderate-to-severe COPD: psychometric results from the SHINE study. Kulich K; Keininger DL; Tiplady B; Banerji D Int J Chron Obstruct Pulmon Dis; 2015; 10():79-94. PubMed ID: 25609942 [TBL] [Abstract][Full Text] [Related]
6. Limitation of Activities of Daily Living and Quality of Life Based on COPD Combined Classification. Barusso MS; Gianjoppe-Santos J; Basso-Vanelli RP; Regueiro EM; Panin JC; Di Lorenzo VA Respir Care; 2015 Mar; 60(3):388-98. PubMed ID: 25492955 [TBL] [Abstract][Full Text] [Related]
7. A cross-sectional assessment of the burden of COPD symptoms in the US and Europe using the National Health and Wellness Survey. Ding B; DiBonaventura M; Karlsson N; Bergström G; Holmgren U Int J Chron Obstruct Pulmon Dis; 2017; 12():529-539. PubMed ID: 28223793 [TBL] [Abstract][Full Text] [Related]
8. Symptom variability in patients with severe COPD: a pan-European cross-sectional study. Kessler R; Partridge MR; Miravitlles M; Cazzola M; Vogelmeier C; Leynaud D; Ostinelli J Eur Respir J; 2011 Feb; 37(2):264-72. PubMed ID: 21115606 [TBL] [Abstract][Full Text] [Related]
9. Does quality of life of COPD patients as measured by the generic EuroQol five-dimension questionnaire differentiate between COPD severity stages? Rutten-van Mölken MP; Oostenbrink JB; Tashkin DP; Burkhart D; Monz BU Chest; 2006 Oct; 130(4):1117-28. PubMed ID: 17035446 [TBL] [Abstract][Full Text] [Related]
10. Effects of adherence to the Mediterranean diet on fatigue and activities of daily living in geriatric individuals with COPD. Arslan S; Bozkurt C; Arslan M; Bulut H Clin Nutr ESPEN; 2023 Apr; 54():436-442. PubMed ID: 36963891 [TBL] [Abstract][Full Text] [Related]
11. Effect of CArbocisteine in Prevention of exaceRbation of chronic obstructive pulmonary disease (CAPRI study): An observational study. Esposito A; Valentino MR; Bruzzese D; Bocchino M; Ponticiello A; Stanziola A; Sanduzzi A Pulm Pharmacol Ther; 2016 Apr; 37():85-8. PubMed ID: 26970503 [TBL] [Abstract][Full Text] [Related]
12. A Cross-Sectional Study in Patients with Severe COPD to Assess the Perception of Symptom Variability (COPVAR) in the Middle East and Africa. Kokturk N; Abuharbid W; Albanna AS; Gunen H; Gurgun A; Khadadah M; Malvolti E; Soliman M; van Zyl-Smit R; Zidouni N; Alzaabi A Int J Chron Obstruct Pulmon Dis; 2019; 14():2959-2970. PubMed ID: 31908444 [TBL] [Abstract][Full Text] [Related]
13. [The importance of the at risk COPD patients (Stage 0) and clinical differences]. Kömüs N; Tertemiz KC; Sevinç C Tuberk Toraks; 2008; 56(4):382-9. PubMed ID: 19123073 [TBL] [Abstract][Full Text] [Related]
14. Cardiac, ventilatory, and metabolic adjustments in chronic obstructive pulmonary disease patients during the performance of Glittre activities of daily living test. Tufanin A; Souza GF; Tisi GR; Tufik S; de Mello MT; Nascimento OA; Jardim JR Chron Respir Dis; 2014 Nov; 11(4):247-55. PubMed ID: 25316708 [TBL] [Abstract][Full Text] [Related]
15. Impact and factors associated with nighttime and early morning symptoms among patients with chronic obstructive pulmonary disease. Stephenson JJ; Cai Q; Mocarski M; Tan H; Doshi JA; Sullivan SD Int J Chron Obstruct Pulmon Dis; 2015; 10():577-86. PubMed ID: 25844033 [TBL] [Abstract][Full Text] [Related]
16. Evaluation of inhaler technique and patient satisfaction with fixed-combination budesonide/formoterol dry-powder inhaler in chronic obstructive pulmonary disease (COPD): data on real-life clinical practice in Turkey. Öztürk C; Kaya A; Bilgin C; Yücesoy L; İkidağ B; Demirel M; Başlılar Ş; Şaylan B; Senol T; Ağanoğlu S; Can G; Doğrul MI; Çam M; Erdoğan N; Batum Ö; Turan MO; Demir C; Torun Ş; Cirit M; Turan M; Keleşoğlu A; Yaşar S; Uzunay Ö; Melek K; Altıparmak O Tuberk Toraks; 2012; 60(4):301-13. PubMed ID: 23289459 [TBL] [Abstract][Full Text] [Related]
17. COPD, chronic bronchitis and capacity for day-to-day activities: negative impact of illness on the health-related quality of life. Kanervisto M; Saarelainen S; Vasankari T; Jousilahti P; Heistaro S; Heliövaara M; Luukkaala T; Paavilainen E Chron Respir Dis; 2010; 7(4):207-15. PubMed ID: 21084545 [TBL] [Abstract][Full Text] [Related]
18. Effect of tiotropium on outcomes in patients with moderate chronic obstructive pulmonary disease (UPLIFT): a prespecified subgroup analysis of a randomised controlled trial. Decramer M; Celli B; Kesten S; Lystig T; Mehra S; Tashkin DP; Lancet; 2009 Oct; 374(9696):1171-8. PubMed ID: 19716598 [TBL] [Abstract][Full Text] [Related]
19. Patient's perception of exacerbations of COPD--the PERCEIVE study. Miravitlles M; Anzueto A; Legnani D; Forstmeier L; Fargel M Respir Med; 2007 Mar; 101(3):453-60. PubMed ID: 16938447 [TBL] [Abstract][Full Text] [Related]
20. Is walking in daily life a moderate intensity activity in patients with chronic obstructive pulmonary disease? Vitorasso R; Camillo CA; Cavalheri V; Aparecida Hernandes N; Cortez Verceze A; Sant'Anna T; Ferreira Monteiro F; Ramos EM; Pitta F Eur J Phys Rehabil Med; 2012 Dec; 48(4):587-92. PubMed ID: 23138677 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]